PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+32.77%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$175M
AUM Growth
+$175M
(+55%)
Cap. Flow
+$38.6M
Cap. Flow
% of AUM
21.99%
Top 10 Holdings %
Top 10 Hldgs %
99.84%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Cardlytics
CDLX
|
$38.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 71.07% |
| 2 | Communication Services | 21.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
X4 Pharmaceuticals
XFOR
$84.2M
| $42.8M | 24.39% |
1,868,957
| – | – |
|
|
2
Cardlytics
CDLX
$54.3M
| $38.6M | 21.99% |
+2,636,262
| New | +$38.6M |
|
3
KALA BIO
KALA
$78.8M
| $29.4M | 16.76% |
1,857,582
| – | – |
|
4
Fate Therapeutics
FATE
$120M
| $24.1M | 13.76% |
2,473,186
| – | – |
|
5
Cartesian Therapeutics
RNAC
$261M
| $16.4M | 9.33% |
1,606,813
| – | – |
|
|
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
| $12.2M | 6.94% |
1,875,524
| – | – |
|
|
ATYR
7
aTyr Pharma
ATYR
$527M
| $4.84M | 2.76% |
1,827,992
| – | – |
|
|
TRVN
8
DELISTED
Trevena, Inc.
TRVN
| $3.37M | 1.92% |
2,053,540
| – | – |
|
|
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
| $2.07M | 1.18% |
1,968,606
| – | – |
|
10
Pulmatrix
PULM
$18M
| $1.42M | 0.81% |
2,796,407
| – | – |
|
11
Dare Bioscience
DARE
$27.2M
| $273K | 0.16% |
326,243
| – | – |
|